These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2243195)

  • 81. Quantitation of IgG antibody to the type-specific polysaccharide of group B streptococcus type 1b in pregnant women and infected infants.
    Gotoff SP; Papierniak CK; Klegerman ME; Boyer KM
    J Pediatr; 1984 Oct; 105(4):628-30. PubMed ID: 6207281
    [No Abstract]   [Full Text] [Related]  

  • 82. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
    Baker CJ; Edwards MS; Webb BJ; Kasper DL
    J Clin Invest; 1982 Feb; 69(2):394-404. PubMed ID: 7035495
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines.
    Brigtsen AK; Kasper DL; Baker CJ; Jennings HJ; Guttormsen HK
    J Infect Dis; 2002 May; 185(9):1277-84. PubMed ID: 12001045
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Antibodies against Streptococcus agalactiae proteins c(alpha) and R4 in sera from pregnant women from Norway and Zimbabwe.
    Moyo SR; Maeland JA; Mudzori J
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1110-4. PubMed ID: 11687448
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Quantitative determination of antibodies to type III group B streptococcal polysaccharide.
    Guttormsen HK; Baker CJ; Edwards MS; Paoletti LC; Kasper DL
    J Infect Dis; 1996 Jan; 173(1):142-50. PubMed ID: 8537651
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Type-specific protection of neonatal rats from lethal group B streptococcal infection by immune sera obtained from human volunteers vaccinated with type III-specific polysaccharide.
    De Cueninck BJ; Eisenstein TK; McIntosh TS; Shockman GD; Swenson RM
    Infect Immun; 1982 Sep; 37(3):961-5. PubMed ID: 6752032
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Immunological aspects of group B streptococcal infections.
    Kretschmer RR; Gotoff SP
    Infection; 1978; 6(4):146-8. PubMed ID: 357294
    [No Abstract]   [Full Text] [Related]  

  • 88. Immune responses to the R4 protein antigen of group B streptococci and its relationship to other streptococcal R4 proteins.
    Fasola EL; Flores AE; Ferrieri P
    Clin Diagn Lab Immunol; 1996 May; 3(3):321-5. PubMed ID: 8705677
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Type-specific serum antibodies against group B streptococci among pregnant women: relation to urogenital carriage and age.
    Lindén V; Christensen KK; Christensen P
    Scand J Infect Dis; 1982; 14(3):189-93. PubMed ID: 6755658
    [No Abstract]   [Full Text] [Related]  

  • 90. [Trial of screening test for prevention on neonatal infections due to group B Streptococcus].
    Hoshina K; Suzuki Y; Amano Y; Onogawa T
    Kansenshogaku Zasshi; 1987 May; 61(5):561-6. PubMed ID: 3117944
    [No Abstract]   [Full Text] [Related]  

  • 91. Maternal immunoglobulin allotype (Gm and Km) and neonatal group B streptococcal infection.
    Thom H; Lloyd DL; Reid TM
    J Immunogenet; 1986 Aug; 13(4):309-14. PubMed ID: 3549908
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effects of route and time of administration of antiserum on protection of mice from lethal infection due to group B Streptococcus type III.
    Stanton BF; Baltimore RS; Shedd DG
    Infect Immun; 1981 Jan; 31(1):391-5. PubMed ID: 7011999
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Immunoprophylaxis and immunotherapy of neonatal group B streptococcal infections.
    Gotoff SP
    Infection; 1985; 13 Suppl 2():S230-5. PubMed ID: 3902656
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Group B streptococci in the milk of lactating mothers.
    Kubín V; Mrastíková H; Paulová M; Motlová J; Franĕk J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jun; 265(1-2):210-7. PubMed ID: 3314258
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Enzyme-linked immunosorbent assay for group B streptococcal antibodies.
    Rote NS; Taylor NL; Shigeoka AO; Scott JR; Hill HR
    Infect Immun; 1980 Jan; 27(1):118-23. PubMed ID: 6987164
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Type classification of group B streptococci by the fluorescent antibody test.
    Bevanger L; Maeland JA
    Acta Pathol Microbiol Scand B; 1977 Dec; 85B(6):357-62. PubMed ID: 415510
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Immunospecificity and quantitation of an enzyme-linked immunosorbent assay for group B streptococcal antibody.
    Anthony BF; Concepcion NF; McGeary SA; Ward JI; Heiner DC; Shapshak P; Insel RA
    J Clin Microbiol; 1982 Aug; 16(2):350-4. PubMed ID: 6181090
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Relation between maternal urogenital carriage of group B streptococci and postmaturity and intrauterine asphyxia during delivery.
    Christensen KK; Dahlander K; Ingemarsson I; Svenningsen N; Christensen P
    Scand J Infect Dis; 1980; 12(4):271-5. PubMed ID: 7006060
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Micro-indirect hemagglutination test for detection of antibodies to the Ibc protein of group B Streptococcus.
    Thangavelu CP; Koshi G
    J Clin Microbiol; 1980 Jul; 12(1):1-6. PubMed ID: 6999011
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Morphological stabilization of capsules of group B streptococci, types Ia, Ib, II, and III, with specific antibody.
    Mackie EB; Brown KN; Lam J; Costerton JW
    J Bacteriol; 1979 May; 138(2):609-17. PubMed ID: 374399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.